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Lung function assessed by home Forced Oscillation and self reported symptoms 
during COPD exacerbations
Partners of the consortium:
• Population: Elderly (>65yrs) COPD patients (GOLD stage ≥2), with at
least one comorbidity and ≥ 1 exacerbation in the previous year,
randomly assigned to an interventional or control group.
• Protocol: For 9 months, monitored patients performed daily self-
assessment of lung mechanics with a FOT (Forced Oscillation
Technique) device and completed a symptom diary card (see Table
1). Any detected worsening in lung mechanics generated an alert
triggering a phone interview directed at verifying the patient's
status and optimizing treatment.
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Please select any WORSENING of 
symptoms ABOVE YOUR USUAL 
daily level:
No changes
increased BREATHLESSNESS (M)
increased SPUTUM COLOUR (M)
increased SPUTUM AMOUNT (M)
increased COUGH (m)
increased WHEEZE or CHEST TIGHTNESS (m)
Do you have one or more of the 
following ?
a COLD such as a runny or blocked nose (m)
FEVER (m)
SORE THROAT (m)
Table 1 – Baseline data
Nr of patients (M/F) 57/13
Age 71,6 ± 5,9
BMI (Kg/m2) 27,4 ± 5,2
Smoking history
(pack/years) 42,8 ± 25,5
%FEV1 postBd 47,8 ± 15,5
%FVC postBd 72,0 ± 19,0
%FEV1/FVC postBd 67,8 ± 18,3
Exacerbations last yr 2,1 ± 1,2
Hospitalizations 
last yr 1 ± 0,9
Methods
• Data from 70 patients in the monitoring arm.
• Patient compliance: number of measures received/number of
scheduled measures.
• A worsening event has been defined as a cluster of persistent alarms
generated within 7 days.
• A symptom-based exacerbation was identified using diary cards if at
least one major and one minor symptom were present for at least 2
consecutive days (Seemungal et al., Am J Respir Crit Care Med 1998).
• Association between a worsening event, a prescribed treatment and
the presence of a symptom-based exacerbation was investigated for
the week preceding and the week after the date of generation of the
first alarm.
Results
Conclusions
CHROMED is an EU-funded, multicenter, randomized trial aimed at
evaluating the socio-economic impact of a home-monitoring platform
on the quality of life of COPD patients with comorbidities.
Fig.1: CHROMED home monitoring platform 
Table 1: Symptom diary card. Major symptom (M), minor symptom(m)   
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• 381 Alarms have been generated in the whole period resulting in
311 worsening events.
• Rate of worsening events per patient was 0,65±0,3 per month.
• 48% of the CHROMED worsening events1 were associated with a
treatment and/or a symptom-based exacerbation. An additional
15% of events was associated with worsening of one major
symptom. (see Fig.4)
• Eight (11% of the population) patients generated 48% of the
asymptomatic untreated worsening events.
• Patients’compliance to the study protocol was high, confirming the
suitability of FOT as an unsupervised monitoring tool in a
community setting.
• The majority of CHROMED events were associated with a treatment
and/or a worsening in lung perceived symptoms.
• In a small group of patients, a worsening in lung mechanic was
neither associated with a worsening in symptoms nor with a
prescribed treatment.
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Fig. 2: Comorbidities distribution. 
Cardiovascular diseases: Congestive heart 
failure, hypertension, ischaemic disease, 
hyperlipaedemia. SDB: Sleep disordered 
breathing.
Population
Patients’ compliance
Fig. 3: FOT measurements and completed questionnaires
Worsening events
Treated events1:
with symptom-based exacerbation 
without symptom-based exacerbation 
Untreated events1 :
with symptom-based exacerbation 
without symptom-based exacerbation: 
with a worsening of  one major symptom 
Fig4: Percentages of worsening events generated by the monitoring platform and 
associated with a treatment and/or an exacerbation or worsening in a major symptom. 
1 101 alarms were excluded since handled more than 48 hours after their 
generation
